Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 8;115(5):447-456.
doi: 10.1093/trstmh/trab045.

COVID-19 vaccines for low- and middle-income countries

Edward M Choi  1
Affiliations
Review

COVID-19 vaccines for low- and middle-income countries

Edward M Choi. Trans R Soc Trop Med Hyg. .

Abstract

The COVID-19 pandemic is the biggest threat to public health in a century. Through hard work and ingenuity, scientists have developed a number of safe and effective vaccines against COVID-19 disease. However, demand far outstrips supply and countries around the world are competing for available vaccines. This review describes how low- and middle-income countries access COVID-19 vaccines, what is being done to distribute vaccines fairly, as well as the challenges ahead.

Keywords: 2019 novel coronavirus disease clinical trial; COVID-19; low- and middle-income countries; severe acute respiratory syndrome coronavirus 2; vaccines.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Global distribution of COVID-19 cases reported by low- and middle-income countries. This figure charts the number of cases recorded by World-o-meter up to 30 January 2021, 1 y after the WHO had declared COVID-19 as a Public Health Emergency of International Concern.
Figure 2.
Figure 2.
Global distribution of COVID-19 direct orders vs populations. Calculations were made using 2019 population figures released by the World Bank and the numbers of confirmed vaccine purchases published by The Duke Global Health Innovation Center.
See this image and copyright information in PMC

References

    1. Worldometers . COVID-19 Coronavirus Pandemic. 2021. Available at https://www.worldometers.info/coronavirus/ [accessed 13 February 2021].
    1. Pullano G, Di Domenico L, Sabbatini CEet al. Underdetection of cases of COVID-19 in France threatens epidemic control. Nature. 2021;590(7844):134–9. - PubMed
    1. Reese H, Iuliano AD, Patel NN, et al. Estimated incidence of COVID-19 illness and hospitalization—United States, February–September, 2020. Clin Infect Dis. 2020; ciaa1780, 10.1093/cid/ciaa1780. - DOI - PMC - PubMed
    1. Dunachie S, Chamnan P. The double burden of diabetes and global infection in low and middle-income countries. Trans R Soc Trop Med Hyg. 2018;113(2):56–64. - PMC - PubMed
    1. Buss LF, Prete CA Jr, Abrahim CMMet al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–92. - PMC - PubMed

Substances